Not for distribution by US newswire or in United States
NESS-ZIONA, Israel, March 07, 2022 (GLOBE NEWSWIRE) -- VAXIL BIO LTD. (“Vaxil” or the “Company”) (TSXV:VXL.VN), an innovative immunotherapy biotech company is pleased to provide an update on its research activities.
Read more at globenewswire.com